A pharma IPO has snatched the crown for the largest US listing of the year.
Royalty Pharma raised $2.2 billion — the exact amount outlined in the latest filing — by pricing at $28 per share, the top of the range. On its first day on the Nasdaq, it’s valued at $16.67 billion.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,